To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions

Comparative, Randomized, Single-Dose, 2-way Crossover Bioavailability Study of Geneva 600 mg Azithromycin Monohydrate Tablets and Pfizer Inc. (Zithromax) 600 mg Azithromycin Dihydrate Tablets in Healthy Adult Volunteers Under Fed Conditions

To demonstrate the bioequivalence of Azithromycin 600 mg Tablets Under Fed Conditions.

Inclusion Criteria:

• No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening

Exclusion Criteria:

• Positive test results for HIV or hepatitis B or C
• Treatment for drug or alcohol dependence
• Female subjects who are pregnant or lactating